Entering text into the input field will update the search result below

Stellar up 118% on reverse merger with Edesa Biotech

Mar. 08, 2019 10:12 AM ETEdesa Biotech, Inc. (EDSA) StockBy: Douglas W. House, SA News Editor2 Comments
  • Thinly traded nano cap Stellar Biotechnologies (SBOT +117.5%) is up on a healthy 38x surge in volume in reaction to its share exchange (reverse merger) with privately held Edesa Biotech.
  • Edesa's lead candidate is EB01, a non-steroidal anti-inflammatory molecule for the potential treatment of allergic contact dermatitis.
  • Under the terms of the deal, Edesa shareholders will exchange their shares for newly issued Stellar shares, becoming a wholly owned subsidiary of Stellar, while owning 90% of the combined company that will do business as Edesa Biotech.
  • The transaction should close next quarter.

Recommended For You

About EDSA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EDSA--
Edesa Biotech, Inc.